Scholars Central

Conference abstractPublished 13 Jul 2015

Biochanin A: An isoflavone with anti-cancer and anti-invasive properties

Authors: Alok Bhushan

Thomas Jefferson University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Some flavonoids are known to exert anti-cancer effects by inhibiting cancer cell progression. Genistein, an isoflavone is bioactive and is present in plant products like soy. Epidemiological studies indicate geographic areas where there is increased human consumption of soy products have a lower incidence of cancer. Although not fully understood, there is some evidence isoflavones target tyrosine phosphorylation, topoisomerases and drug transporters. Our studies have therefore the goal of elucidating the molecular mechanisms underlying the putative anti-cancer effect of Biochanin A (5,7-Dihydroxy-4'-methoxyisoflavone, BioA), which is an isoflavone present in red clover, chick peas, soy, peanuts and many legumes. We noted BioA blocked the proliferation of glioblastoma, breast, pancreatic and oral squamous cancer cells. We observed BioA inhibited cell signaling pathways (e.g., MAP kinase, PI3kinase and mTOR) involved in tumor progression and matrix-metalloproteases, resulting in blocking invasion of the cancer cells. Angiogenesis is necessary for the progression of cancer cells to form tumors: Thus, tumors release angiogenic factors to stimulate the growth of capillaries that supply nutrients and oxygen to them. Consistent with the latter generation is our observation that chemical induced hypoxia increased expression of hypoxia-inducible factor and VEGF in C6 rat glioma cells: BioA blocked this effect and the proliferation and migration of bEnd.3 endothelial cells. BioA also sensitized glioma cells to tamador, a drug for treating glioblastoma. Our findings strongly suggest BioA present in the diet may suppress tumor growth and be used in prevention and combination chemotherapy that would lead to a better outcome of cancer treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Alok Bhushan”